Related Experiment Video
Updated: Feb 18, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Prospect of Using Cell Product for the Therapy of Skin Defects in Diabetes Mellitus
A P Lykov1,2, N A Bondarenko3,4, O V Poveshchenko3,4
1Research Institute of Clinical and Experimental Lymphology, Novosibirsk, Russia. aplykov2@mail.ru.
Abstract:
The effectiveness of autologous cell product in the therapy of skin burn wounds was studied in C57B1/6 male mice against the background of streptozotocin-induced diabetes mellitus. In animals with and without modeled diabetes mellitus, significant decrease in skin defect area was observed after single administration of the cell product (bone marrow multipotent mesenchymal stromal cells, fibroblasts or media conditioned by these cells).
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
iPS Cell Differentiation
Stem Cell Culture
Induced Pluripotent Stem Cells
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

